Skip to main content

Introduction: pegfilgrastim, a new era in the management of chemotherapy-induced neutropenia.

Publication ,  Journal Article
Petros, WP
Published in: Pharmacotherapy
August 2003

Duke Scholars

Published In

Pharmacotherapy

DOI

ISSN

0277-0008

Publication Date

August 2003

Volume

23

Issue

8 Pt 2

Start / End Page

1S / 2S

Location

United States

Related Subject Headings

  • Recombinant Proteins
  • Polyethylene Glycols
  • Pharmacology & Pharmacy
  • Neutropenia
  • Humans
  • Granulocyte Colony-Stimulating Factor
  • Filgrastim
  • Clinical Trials as Topic
  • Antineoplastic Agents
  • 3214 Pharmacology and pharmaceutical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Petros, W. P. (2003). Introduction: pegfilgrastim, a new era in the management of chemotherapy-induced neutropenia. Pharmacotherapy, 23(8 Pt 2), 1S-2S. https://doi.org/10.1592/phco.23.9.1s.32890
Petros, William P. “Introduction: pegfilgrastim, a new era in the management of chemotherapy-induced neutropenia.Pharmacotherapy 23, no. 8 Pt 2 (August 2003): 1S-2S. https://doi.org/10.1592/phco.23.9.1s.32890.
Petros, William P. “Introduction: pegfilgrastim, a new era in the management of chemotherapy-induced neutropenia.Pharmacotherapy, vol. 23, no. 8 Pt 2, Aug. 2003, pp. 1S-2S. Pubmed, doi:10.1592/phco.23.9.1s.32890.

Published In

Pharmacotherapy

DOI

ISSN

0277-0008

Publication Date

August 2003

Volume

23

Issue

8 Pt 2

Start / End Page

1S / 2S

Location

United States

Related Subject Headings

  • Recombinant Proteins
  • Polyethylene Glycols
  • Pharmacology & Pharmacy
  • Neutropenia
  • Humans
  • Granulocyte Colony-Stimulating Factor
  • Filgrastim
  • Clinical Trials as Topic
  • Antineoplastic Agents
  • 3214 Pharmacology and pharmaceutical sciences